130 related articles for article (PubMed ID: 14602179)
1. Disintegrating pellets from a water-insoluble pectin derivative produced by extrusion/spheronisation.
Tho I; Sande SA; Kleinebudde P
Eur J Pharm Biopharm; 2003 Nov; 56(3):371-80. PubMed ID: 14602179
[TBL] [Abstract][Full Text] [Related]
2. Pectinic acid, a novel excipient for production of pellets by extrusion/spheronisation: preliminary studies.
Tho I; Sande SA; Kleinebudde P
Eur J Pharm Biopharm; 2002 Jul; 54(1):95-9. PubMed ID: 12084508
[TBL] [Abstract][Full Text] [Related]
3. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.
Dukić-Ott A; Thommes M; Remon JP; Kleinebudde P; Vervaet C
Eur J Pharm Biopharm; 2009 Jan; 71(1):38-46. PubMed ID: 18771727
[TBL] [Abstract][Full Text] [Related]
4. Influence of MCC II fraction and storage conditions on pellet properties.
Krueger C; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
[TBL] [Abstract][Full Text] [Related]
5. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
[TBL] [Abstract][Full Text] [Related]
6. Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion-spheronisation aid.
Jain SP; Mehta DC; Shah SP; Singh PP; Amin PD
AAPS PharmSciTech; 2010 Jun; 11(2):917-23. PubMed ID: 20499219
[TBL] [Abstract][Full Text] [Related]
7. Extrusion/spheronization of pectin-based formulations. I. Screening of important factors.
Tho T; Kleinebudde P; Sande SA
AAPS PharmSciTech; 2001 Dec; 2(4):26. PubMed ID: 14727863
[TBL] [Abstract][Full Text] [Related]
8. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
9. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
[TBL] [Abstract][Full Text] [Related]
10. Supramolecular elucidation of the quality attributes of microcrystalline cellulose and isomalt composite pellet cores.
Antal I; Kállai N; Luhn O; Bernard J; Nagy ZK; Szabó B; Klebovich I; Zelkó R
J Pharm Biomed Anal; 2013 Oct; 84():124-8. PubMed ID: 23827942
[TBL] [Abstract][Full Text] [Related]
11. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
Chatchawalsaisin J; Podczeck F; Newton JM
Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
[TBL] [Abstract][Full Text] [Related]
12. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
Verheyen P; Steffens KJ; Kleinebudde P
Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
[TBL] [Abstract][Full Text] [Related]
13. Quantum chemical descriptors in the formulation of pectin pellets produced by extrusion/spheronisation.
Tho I; Anderssen E; Dyrstad K; Kleinebudde P; Sande SA
Eur J Pharm Sci; 2002 Aug; 16(3):143-9. PubMed ID: 12128168
[TBL] [Abstract][Full Text] [Related]
14. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.
Goyanes A; Martínez-Pacheco R
Drug Dev Ind Pharm; 2015 Mar; 41(3):362-8. PubMed ID: 24279425
[TBL] [Abstract][Full Text] [Related]
15. Design and optimization of disintegrating pellets of MCC by non-aqueous extrusion process using statistical tools.
Gurram RK; Gandra S; Shastri NR
Eur J Pharm Sci; 2016 Mar; 84():146-56. PubMed ID: 26812204
[TBL] [Abstract][Full Text] [Related]
16. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
[TBL] [Abstract][Full Text] [Related]
17. Development of starch-based pellets via extrusion/spheronisation.
Dukić A; Mens R; Adriaensens P; Foreman P; Gelan J; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2007 Apr; 66(1):83-94. PubMed ID: 17045467
[TBL] [Abstract][Full Text] [Related]
18. Immediate release pellets with lipid binders obtained by solvent-free cold extrusion.
Krause J; Thommes M; Breitkreutz J
Eur J Pharm Biopharm; 2009 Jan; 71(1):138-44. PubMed ID: 18805483
[TBL] [Abstract][Full Text] [Related]
19. Quantification of mass transfer during spheronisation.
Koester M; Thommes M
AAPS PharmSciTech; 2012 Jun; 13(2):493-7. PubMed ID: 22415640
[TBL] [Abstract][Full Text] [Related]
20. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]